The Furnace Stack (L-Carnitine Blend)
Also Known As: Carnitine, Levocarnitine, ALCAR, Acetyl-L-Carnitine, L-Carnitine tartrate, Propionyl-L-Carnitine, L-Carnitine fumarate, Carnitor, VitaCarn, L-Carnitine injection, Levacecarnine, Beta-hydroxy-gamma-trimethylaminobutyric acid, Carnitine base, Mitochondrial transport factor, Fat transport molecule, levocarnitine
The Furnace Stack (L-Carnitine Blend) is a research-grade Conditionally essential amino acid derivative targeting Carnitine palmitoyltransferase I/II studied in Weight Loss & Metabolism research. It is supplied strictly for in vitro laboratory research use only - not for human or animal consumption, and not FDA-approved.
Evidence Tier: Approved Drug - FDA and/or EMA approved with robust human trial data.
A fat-metabolism nutrient with an approved deficiency drug form.
At A Glance
| Category | Weight Loss & Metabolism |
|---|---|
| Compound Class | Conditionally essential amino acid derivative (betaine analog); mitochondrial fatty acid transport molecule |
| Molecular Target | Carnitine palmitoyltransferase I/II (CPT1/CPT2); transports long-chain fatty acids into mitochondrial matrix for beta-oxidation |
| Molecular Weight | 161.2 Da |
| Amino Acid Sequence | quaternary amine derivative |
| CAS Number | 541-15-1 |
| Half-Life | ~15 hours |
| WADA Status | permitted |
| Evidence Tier | Approved Drug |
Mechanism Of Action
It is the essential transport vehicle that carries fatty acids across the mitochondrial membrane. Without it, fat cannot enter the cellular engine to be oxidized and used as fuel.
Studied For
- Fat oxidation / fatty acid transport
- Energy metabolism
- Exercise performance
- Cognitive support / brain energy
- Carnitine deficiency
- Peripheral artery disease
- Cardiovascular disease models
- Male infertility / sperm motility
- Insulin resistance models
- Dialysis-related carnitine deficiency
- Weight management adjunct
- Muscle recovery
- Fatigue reduction
- Mitochondrial function support
- Hepatic fat metabolism
- Athletic endurance enhancement
- Neuroprotection research
- fat transport
- fat burning
- energy production
- mitochondrial support
- weight loss
- athletic performance
Reported Research Findings
Levocarnitine is approved for carnitine deficiency. Supportive but mixed data exist for liver fat, cardiovascular endpoints, and (for the acetyl form) mood and neuropathy.
Safety And Handling Notes
At higher doses: nausea, cramps, diarrhea, and a fishy body odor. Use only the L (levo) form; D and DL forms are toxic.
An approved drug for deficiency; permitted in sport (only IV-infusion volume limits apply). Caution with seizure history and in kidney disease.
Regulatory Status
Levocarnitine FDA-approved Rx; also a supplement.
Full Reference Detail
Related Research Guides
Maintained By The Pep Nation Lab Research Team. See Our Editorial Standards And Research Methodology For How This Reference Is Sourced And Reviewed.
This Reference Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption. See The Full Research Disclaimer.